These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15283137)

  • 1. [International estimation of molecular target drug].
    Fujisaka Y; Saijo N
    Nihon Rinsho; 2004 Jul; 62(7):1225-31. PubMed ID: 15283137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III].
    Wu W; Lu C; Chen SY; Yu NF
    Yao Xue Xue Bao; 2009 Mar; 44(3):242-57. PubMed ID: 19449520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for the development of novel anticancer drugs.
    Saijo N; Tamura T; Nishio K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting signaling pathways in ovarian cancer.
    Reibenwein J; Krainer M
    Expert Opin Ther Targets; 2008 Mar; 12(3):353-65. PubMed ID: 18269344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
    Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of molecular-target based drug].
    Sone S; Kakiuchi S; Yano S
    Nihon Rinsho; 2004 Jul; 62(7):1232-40. PubMed ID: 15283138
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular targeting drugs--present status and future development].
    Kuwano M; Fujii T; Ono M; Izumi H; Kohno K
    Nihon Rinsho; 2004 Jul; 62(7):1211-5. PubMed ID: 15283135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Target selectivity of anticancer drugs].
    Fattoruso SI; Di Lauro L; Conti F; Amodio A; Lopez M
    Clin Ter; 2008; 159(3):189-206. PubMed ID: 18594750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.
    Browning DD
    Expert Opin Ther Targets; 2008 Mar; 12(3):367-76. PubMed ID: 18269345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A target or a demi-target.
    Mok TS
    Clin Lung Cancer; 2010 May; 11(3):147-8. PubMed ID: 20439189
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers and dendritic polymers in drug delivery.
    Gillies ER; Fréchet JM
    Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted cancer therapeutics.
    Hait WN; Hambley TW
    Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delcath Systems' phase III trial for inoperable cancer is planned at Sydney Melanoma Unit.
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):138-9. PubMed ID: 12113232
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular pathogenetics of renal cancer.
    Skolarikos AA; Papatsoris AG; Alivizatos G; Deliveliotis C
    Am J Nephrol; 2006; 26(3):218-31. PubMed ID: 16733347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized delivery of anti-cancer drugs by electroporation.
    Featherstone C
    Mol Med Today; 1998 Feb; 4(2):47. PubMed ID: 9547785
    [No Abstract]   [Full Text] [Related]  

  • 19. A two-stage algorithm for designing phase I cancer clinical trials for two new molecular entities.
    Su Z
    Contemp Clin Trials; 2010 Jan; 31(1):105-7. PubMed ID: 19879974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principle and practice of clinical phase III studies].
    Morant R
    Onkologie; 2008; 31 Suppl 2():53-7. PubMed ID: 18487870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.